Pdf Viewer

Lenacapavir-associated drug resistance: implications for scaling up long-acting PrEP
recommended

World Health Organization WHO (2025) C_WHO
Source:  https://iris.who.int/bitstream/handle/10665/381889/B09481-eng.pdf

The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF